The Mount Sinai Hospital
Based in NY
AI Overview
With $3.6M in lobbying spend across 32 quarterly filings, The Mount Sinai Hospital is a significant lobbying presence. Their lobbying covers 6 issue areas. Active from 2018 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $810K |
| 2019 | $360K |
| 2020 | $290K |
| 2021 | $420K |
| 2022 | $260K |
| 2023 | $480K |
| 2024 | $380K |
| 2025 | $610K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that The Mount Sinai Hospital disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Medicare/Medicaid, Taxation, MED, Homeland Security and 1 more
H.R.; An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018; Provisions related to tax implications for higher education, pat
H.R. 5818/S. 2843O; Opioid Workforce Act of 2018; All provisions.
Issues related to the 340B program.
Issues related to organ transplantation equity.
Issues related to Medicaid Graduate Medical Edu
H.R. 5818/S. 2843; Opioid Workforce Act of 2018; All provisions.
Issues related to HOPD rate cuts.
Issues related to the 340B program.
Issues related to organ transplantation equity.
Issues relate
Issues related to HOPD rate cuts.
Issues related to the 340B program.
Issues related to organ transplantation equity.
Issues related to the FDA regulation of laboratory developed tests.
Issues rel
Issues related to HOPD rate cuts.
Issues related to the 340B program.
Issues related to organ transplantation equity.
Issues related to the FDA regulation of laboratory developed tests.
Issues related
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.